MedPath

Solclav

Brand Name: Solclav

Generic Name: Co-Amoxiclav

Active
Registration Number

DRP-615-06

Dosage Form

Film-Coated Tablet

Issuance Date

April 1, 2022

Expiry Date

April 2, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500 mg/ 125 mg
PackagingFoil Strip x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Penicillin + Beta-Lactamse Inhibitor combination))
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Co-AmoxiclavActive
Monograph: co-amoxiclav

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform